AVAX ONE (AVX) CEO Jolie Kahn adds to stake with buys and grants

Rhea-AI Filing Summary

AVAX ONE TECHNOLOGY LTD. Chief Executive Officer Jolie Kahn reported a mix of open-market purchases and share grants of common shares. Kahn bought 3,000 shares at 1.65 and 1,000 shares at 1.70 in open-market transactions, increasing her direct holdings to 171,597 shares after the latest trade.

She also acquired 15,698 and 151,899 common shares through grants or awards. A footnote explains that for one grant, both the share count and price were adjusted for a 1:9 reverse stock split that occurred after the original grant date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KAHN JOLIE

(Last) (First) (Middle)

215 S. OLIVE AVE., STE 201

(Street)

WEST PALM BEACH, FL 33401

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVAX ONE TECHNOLOGY LTD. [ AVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
05/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares(1)	05/30/2025		A		15,698	A	$13.14	15,698	D
Common Shares(2)	09/18/2025		A		151,899	A	$2.39	167,597	D
Common Shares	11/21/2025		P		3,000	A	$1.65	170,597	D
Common Shares	11/24/2025		P		1,000	A	$1.7	171,597	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Price on date of grant. Both number of shares and price adjusted for 1:9 reverse stock split occurring subsequent to date of grant.

2. Price on date of grant.

	/s/ Jolie Kahn	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did AVAX ONE (AVX) CEO Jolie Kahn report?

Jolie Kahn reported both open-market purchases and share grants of AVAX ONE common shares. She bought 4,000 shares in total and also received two sizeable grants, reflecting increased direct ownership as documented in this Form 4 filing.

How many AVAX ONE (AVX) shares did the CEO buy in the open market?

The CEO purchased 3,000 AVAX ONE common shares at 1.65 per share and 1,000 shares at 1.70 per share. These open-market purchases increased her directly held position as reflected in the post-transaction ownership figure of 171,597 shares.

What share grants to the AVAX ONE (AVX) CEO are disclosed in this Form 4?

The filing shows the CEO acquired 15,698 common shares and 151,899 common shares through grants or awards. One grant’s share count and price were adjusted for a 1:9 reverse stock split that occurred after the original grant date, according to the footnote.

What is Jolie Kahn’s total AVAX ONE (AVX) ownership after these transactions?

After the latest reported transaction, Jolie Kahn directly holds 171,597 AVAX ONE common shares. This figure incorporates the disclosed open-market purchases and prior grants or awards, providing an updated snapshot of her direct equity stake in the company.

How did the reverse stock split affect the AVAX ONE (AVX) CEO grant figures?

A footnote states that for one CEO share grant, both the number of shares and the grant price were adjusted for a 1:9 reverse stock split. This means the disclosed grant figures already reflect the post-split share count and price per share.